sarepta fda elevidys - Search News

Order byBest matchMost fresh

FDA asks Sarepta to stop shipping gene therapy

· 1d · on MSN

Sarepta says it won't comply with FDA request to stop shipping gene therapy Elevidys

U.S. regulators asked Sarepta Therapeutics (SRPT.O) on Friday to voluntarily halt shipments of its Elevidys gene therapy after a muscular dystrophy patient who received a different, experimental trea...

Continue reading

Sarepta’s Risky Gamble: Gene Therapy Stays on Market Despite FDA Request

· 1d · on MSN

Sarepta Refused FDA’s Request to Halt Elevidys Shipments

Sarepta tells FDA it won’t halt shipments despite patient deaths

Drugmaker Sarepta Therapeutics said late Friday it won’t comply with a request from the Food and Drug Administration to halt all shipments of its gene therapy following the death of a third patient r...

Continue reading

Sarepta Therapeutics crisis is huge blow to Duchenne families, company

Exclusive: US FDA to request Sarepta to stop all shipments of gene therapy Elevidys, source says

Sarepta Therapeutics Announces Layoff of 493 Employees, Including 80 in Ohio, Amid FDA Scrutiny and Stock Decline

Sarepta Therapeutics lays off 493 workers amid FDA probe, stock drop, and concerns over its gene therapy treatment, Elevidys.